Skip to main content

Relevance of Flammer Syndrome Phenotype to Metastatic Breast Cancer: Risks by Pre-metastatic Systemic Hypoxic Environment

International Multi-centre Study

  • Chapter
  • First Online:
Flammer Syndrome

Abstract

Metastatic disease is the major cause of the death in breast cancer patient (BC) cohorts. Lymph nodes, bones, lung, liver and brain are the most frequently reported sites of the metastatic disease in BC. For example, over 20% of the entire patients’ cohort suffering from aggressive metastases in the liver are individuals with primary tumours diagnosed in the breast. Further, the brain is one of the predominant sites of the metastatic disease recorded for more than 20% of some specific BC subgroups, although in BC-free populations primary brain tumours is a rare disorder. This phenomenon has not been yet adequately explained.

The achievements of our international project have substantially extended the currently existing knowledge regarding the “Seed and Soil” theory of metastasis clearly demonstrating that a strong predisposition of individuals at risk to form the systemic hypoxic pre-metastatic niches can be established a long time before the breast malignancy is clinically manifested. The Flammer syndrome (FS) phenotype may strongly contribute to the aggressive metastatic disease. The exploitation of the acquired knowledge might be performed by creating innovative screening programmes. Contextually, we propose the FS-questionnaire to be considered by family doctors (GPs) for its practical application to the general population, in order to improve the quality of primary care by developing novel more effective approaches for the targeted prevention of the metastatic BC.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

BC:

breast cancer

BMI:

body mass index

CTC:

circulating tumour cells

ECM:

extra-cellular matrix

FIA:

fibro-adenoma

FS:

Flammer Syndrome

GPs:

general practitioners (family doctors)

HER-2:

human epidermal growth factor receptor 2

HIF-1:

hypoxia-inducible factor 1

VEGF:

vascular endothelial growth factor

ТxNxМx:

tumour size/number of affected lymph nodes/number of metastases

References

  1. Golubnitschaja O, Debald M, Yeghiazaryan K, Kuhn W, Pešta M, Costigliola V et al (2016) Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures. Tumor Biol 37(10):12941–12957. https://doi.org/10.1007/s13277-016-5168-x

    Article  Google Scholar 

  2. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A (2015) Global cancer statistics, 2012. CA Cancer J Clin 65(2):87–108. https://doi.org/10.3322/caac.21262

    Article  PubMed  Google Scholar 

  3. Golubnitschaja O, Sridhar KC (2016) Liver metastatic disease: new concepts and biomarker panels to improve individual outcomes. Clin Exp Metastasis 33(8):743–755. https://doi.org/10.1007/s10585-016-9816-8

    Article  CAS  PubMed  Google Scholar 

  4. Lin NU, Bellon JR, Winer EP (2004) CNS metastases in breast cancer. J Clin Oncol 22(17):3608–3617

    Article  PubMed  Google Scholar 

  5. Chang EL, Lo S (2003) Diagnosis and management of central nervous system metastases from breast cancer. Oncologist 8(5):398–410

    Article  PubMed  Google Scholar 

  6. Polivka J, Kralickova M, Polivka J, Kaiser C, Kuhn W, Golubnitschaja O (2017) Mystery of the brain metastatic disease in breast cancer patients: improved patient stratification, disease prediction and targeted prevention on the horizon? EPMA J 8(2):119–127. https://doi.org/10.1007/s13167-017-0087-5

    Article  PubMed  PubMed Central  Google Scholar 

  7. Vaz-Luis I, Lin NU, Keating NL, Barry WT, Winer EP, Freedman RA (2017) Factors associated with early mortality among patients with de novo metastatic breast cancer: a population-based study. Oncologist 22(4):386–393. https://doi.org/10.1634/theoncologist.2016-0369

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Wu X, Baig A, Kasymjanova G, Kafi K, Holcroft C, Mekouar H et al (2016) Pattern of local recurrence and distant metastasis in breast cancer by molecular subtype. Cureus 8(12):e924

    PubMed  PubMed Central  Google Scholar 

  9. Chung IY, Lee JW, Lee JS, Park YR, Min YH, Lee Y et al (2017) Interaction between body mass index and hormone-receptor status as a prognostic factor in lymph-node-positive breast cancer. PloS One 12(3):e0170311. https://doi.org/10.1371/journal.pone.0170311

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Wang J, Wang J, Li Q, Zhang P, Yuan P, Ma F et al (2017) Young breast cancer patients who develop distant metastasis after surgery have better survival outcomes compared with elderly counterparts. Oncotarget 8(27):44851–44859. https://doi.org/10.18632/oncotarget.15268

    Article  PubMed  PubMed Central  Google Scholar 

  11. Masuda T, Hayashi N, Iguchi T, Ito S, Eguchi H, Mimori K (2016) Clinical and biological significance of circulating tumor cells in cancer. Mol Oncol 10(3):408–417. https://doi.org/10.1016/j.molonc.2016.01.010

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Suchorska WM, Lach MS (2016) The role of exosomes in tumor progression and metastasis (Review). Oncol Rep 35(3):1237–1244. https://doi.org/10.3892/or.2015.4507

    Article  CAS  PubMed  Google Scholar 

  13. Høye AM, Erler JT (2016) Structural ECM components in the premetastatic and metastatic niche. Am J Physiol 310(11):C955–C967. https://doi.org/10.1152/ajpcell.00326.2015

    Article  Google Scholar 

  14. Schito L, Rey S, Tafani M, Zhang H, Wong CC-L, Russo A et al (2012) Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells. Proc Natl Acad Sci U S A 109(40):E2707–E2716. https://doi.org/10.1073/pnas.1214019109

    Article  PubMed  PubMed Central  Google Scholar 

  15. Semenza GL (2016) The hypoxic tumor microenvironment: a driving force for breast cancer progression. Biochim Biophys Acta 1863(3):382–391. https://doi.org/10.1016/j.bbamcr.2015.05.036

    Article  CAS  PubMed  Google Scholar 

  16. Pantel K, Cote RJ, Fodstad O (1999) Detection and clinical importance of micrometastatic disease. J Natl Cancer Inst 91(13):1113–1124

    Article  CAS  PubMed  Google Scholar 

  17. Fidler IJ, Yano S, Zhang R-D, Fujimaki T, Bucana CD (2002) The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol 3(1):53–57

    Article  CAS  PubMed  Google Scholar 

  18. Rutkowski MR, Svoronos N, Perales-Puchalt A, Conejo-Garcia JR (2015) The tumor macroenvironment: cancer-promoting networks beyond tumor beds. Adv Cancer Res 128:235–262. https://doi.org/10.1016/bs.acr.2015.04.011

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Chin AR, Wang SE (2016) Cancer tills the premetastatic field: mechanistic basis and clinical implications. Clin Cancer Res 22(15):3725–3733. https://doi.org/10.1158/1078-0432.CCR-16-0028

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Golubnitschaja O (2017) Feeling cold and other underestimated symptoms in breast cancer: anecdotes or individual profiles for advanced patient stratification? EPMA J 8(1):17–22. https://doi.org/10.1007/s13167-017-0086-6

    Article  PubMed  PubMed Central  Google Scholar 

  21. Konieczka K, Choi HJ, Koch S, Schoetzau A, Küenzi D, Kim DM (2014) Frequency of symptoms and signs of primary vascular dysregulation in Swiss and Korean populations. Klin Monatsbl Augenheilkd 231(4):344–347

    Article  CAS  PubMed  Google Scholar 

  22. Konieczka K, Fränkl S (2013) Primäre vaskuläre Dysregulation und Glaukom (Primary vascular dysregulation and glaucoma). Primäre Vaskuläre Dysregulation Glaukom Prim Vasc Dysregulation Glaucoma 34:207–215

    Google Scholar 

  23. Konieczka K, Koch S, Binggeli T, Schoetzau A, Kesselring J (2016) Multiple sclerosis and primary vascular dysregulation (Flammer syndrome). EPMA J 7:13. https://doi.org/10.1186/s13167-016-0062-6

    Article  PubMed  PubMed Central  Google Scholar 

  24. Konieczka K, Koch S, Schoetzau A, Todorova MG (2016) Increased prevalence of flammer syndrome in patients with retinitis pigmentosa. Klin Monatsbl Augenheilkd 233(4):448–452. https://doi.org/10.1055/s-0041-111802

    Article  CAS  PubMed  Google Scholar 

  25. Konieczka K, Todorova MG, Chackathayil TN, Henrich PB (2015) Cilioretinal artery occlusion in a young patient with flammer syndrome and increased retinal venous pressure. Klin Monatsbl Augenheilkd 232(4):576–578

    Article  CAS  PubMed  Google Scholar 

  26. Konieczka K, Flammer J, Sternbuch J, Binggeli T, Fraenkl S (2017) Leber’s hereditary optic neuropathy, normal tension glaucoma, and flammer syndrome: long term follow-up of a patient. Klin Monatsbl Augenheilkd 234(4):584–587. https://doi.org/10.1055/s-0042-119564

    Article  CAS  PubMed  Google Scholar 

  27. Yeghiazaryan K, Flammer J, Golubnitschaja O (2010) Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs. EPMA J 1(2):263–272. https://doi.org/10.1007/s13167-010-0032-3

    Article  PubMed  PubMed Central  Google Scholar 

  28. Zubor P, Gondova A, Polivka J Jr, Kasajova P, Konieczka K, Danko J et al (2017) Breast cancer and Flammer syndrome: any symptoms in common for prediction, prevention and personalised medical approach? EPMA J 8(2):129–140. https://doi.org/10.1007/s13167-017-0089-3

    Article  PubMed  PubMed Central  Google Scholar 

  29. Konieczka K, Ritch R, Traverso CE, Kim DM, Kook MS, Gallino A et al (2014) Flammer syndrome. EPMA J 5(1):11. https://doi.org/10.1186/1878-5085-5-11

    Article  PubMed  PubMed Central  Google Scholar 

  30. On the approval and implementation of medical and technological documents for standardisation of medical care of breast cancer [Internet]. Governmental Directive Number 396; Available from: http://www.moz.gov.ua/docfiles/dn_20150630_0396_ukp_dod.pdf

  31. Golubnitschaja O, Yeghiazaryan K, Liu R, Mönkemann H, Leppert D, Schild H et al (2004) Increased expression of matrix metalloproteinases in mononuclear blood cells of normal-tension glaucoma patients. J Glaucoma 13(1):66–72

    Article  PubMed  Google Scholar 

  32. Golubnitschaja O, Yeghiazaryan K, Stricker H, Trog D, Schild HH, Berliner L (2016) Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours. BMC Cancer 16(1):357. https://doi.org/10.1186/s12885-016-2382-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Mohan P, Antonelou M, Dadzie O, Dubrey S (2015) Headache in a young woman: leptomeningeal metastasis as the first presentation of underlying breast malignancy. BMJ Case Rep 2015:bcr2014207643. https://doi.org/10.1136/bcr-2014-207643

    Article  PubMed  PubMed Central  Google Scholar 

  34. Manders P, Sweep FCGJ, Tjan-Heijnen VCG, Geurts-Moespot A, van Tienoven DTH, Foekens JA et al (2003) Vascular endothelial growth factor independently predicts the efficacy of postoperative radiotherapy in node-negative breast cancer patients. Clin Cancer Res 9(17):6363–6370

    CAS  PubMed  Google Scholar 

  35. Pal SK, Vuong W, Zhang W, Deng J, Liu X, Carmichael C et al (2015) Clinical and translational assessment of VEGFR1 as a mediator of the premetastatic niche in high-risk localized prostate cancer. Mol Cancer Ther 14(12):2896–2900. https://doi.org/10.1158/1535-7163.MCT-15-0367

    Article  CAS  PubMed  Google Scholar 

  36. Avishai E, Yeghiazaryan K, Golubnitschaja O (2017) Impaired wound healing: facts and hypotheses for multi-professional considerations in predictive, preventive and personalised medicine. EPMA J 8(1):23–33. https://doi.org/10.1007/s13167-017-0081-y

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Olga Golubnitschaja .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bubnov, R., Polivka, J., Zubor, P., Konieczka, K., Golubnitschaja, O. (2019). Relevance of Flammer Syndrome Phenotype to Metastatic Breast Cancer: Risks by Pre-metastatic Systemic Hypoxic Environment. In: Golubnitschaja, O. (eds) Flammer Syndrome. Advances in Predictive, Preventive and Personalised Medicine, vol 11. Springer, Cham. https://doi.org/10.1007/978-3-030-13550-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-13550-8_14

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-13549-2

  • Online ISBN: 978-3-030-13550-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics